Subtopic Deep Dive
Toxicology of Mitragyna Speciosa Alkaloids
Research Guide
What is Toxicology of Mitragyna Speciosa Alkaloids?
Toxicology of Mitragyna speciosa alkaloids examines the adverse effects, hepatotoxicity, seizures, and dependence potential of mitragynine and related compounds from kratom leaves.
Researchers use case reports, LC-MS analysis, and animal models to assess acute toxicity like seizures (Nelsen et al., 2010, 160 citations) and chronic effects such as intrahepatic cholestasis (Kapp et al., 2011, 139 citations). Over 20 papers detail pharmacokinetics and drug interactions, with mitragynine showing a 1-day half-life in humans (Wananukul et al., 2015, 130 citations). Key toxicology reviews cover abuse potential and clinical implications (Warner et al., 2015, 206 citations; Eastlack et al., 2020, 166 citations).
Why It Matters
Toxicity profiles from LC-MS case reports guide FDA scheduling debates and harm reduction for 1.7 million US kratom users (Grundmann and Veltri, 2019, 142 citations). Hepatotoxicity data from powdered kratom abuse informs clinical management of cholestasis (Kapp et al., 2011). Dependence risk assessments using the 8-factor Controlled Substances Act criteria support regulatory research (Henningfield et al., 2017, 133 citations), influencing safe dosing in pain therapy (Eastlack et al., 2020).
Key Research Challenges
Variable Alkaloid Toxicity Profiles
Mitragynine concentrations vary by plant strain and extraction, complicating dose-response models in case reports (Warner et al., 2015). Human pharmacokinetics show linearity but long half-life raises accumulation risks (Wananukul et al., 2015). Animal models lack standardization for hepatotoxicity endpoints.
Distinguishing Kratom from Polydrug Effects
Fatalities often involve mitragynine with propylhexedrine or alcohol, obscuring primary toxicology (Holler et al., 2011, 102 citations; McIntyre et al., 2014, 103 citations). Postmortem LC-MS struggles with metabolite identification. Case reports like seizures lack controls (Nelsen et al., 2010).
Chronic Dependence Mechanisms
Opioid-like withdrawal lacks receptor binding data beyond mitragynine (Cinosi et al., 2015, 219 citations). Longitudinal studies are absent, relying on surveys. Regulatory 8-factor analysis highlights abuse potential gaps (Henningfield et al., 2017).
Essential Papers
Alkaloids Used as Medicines: Structural Phytochemistry Meets Biodiversity—An Update and Forward Look
Michael Heinrich, Jeffrey Mah, Vafa Amirkia · 2021 · Molecules · 325 citations
Selecting candidates for drug developments using computational design and empirical rules has resulted in a broad discussion about their success. In a previous study, we had shown that a species’ a...
Following “the Roots” of Kratom (<i>Mitragyna speciosa</i>): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries
Eduardo Cinosi, Giovanni Martinotti, Pierluigi Simonato et al. · 2015 · BioMed Research International · 219 citations
The use of substances to enhance human abilities is a constant and cross-cultural feature in the evolution of humanity. Although much has changed over time, the availability on the Internet, often ...
The pharmacology and toxicology of kratom: from traditional herb to drug of abuse
Marcus L. Warner, Nellie C. Kaufman, Oliver Grundmann · 2015 · International Journal of Legal Medicine · 206 citations
Kratom—Pharmacology, Clinical Implications, and Outlook: A Comprehensive Review
Steven Eastlack, Elyse M. Cornett, Alan D. Kaye · 2020 · Pain and Therapy · 166 citations
Seizure and Coma Following Kratom (Mitragynina speciosa Korth) Exposure
Jamie L. Nelsen, Jeff Lapoint, Michael Hodgman et al. · 2010 · Journal of Medical Toxicology · 160 citations
Evaluation of Antioxidant and Antibacterial Activities of Aqueous, Methanolic and Alkaloid Extracts from Mitragyna Speciosa (Rubiaceae Family) Leaves
Suhanya Parthasarathy, Juzaili Azizi, Surash Ramanathan et al. · 2009 · Molecules · 159 citations
Studies on the antioxidant and antimicrobial activities of Mitragyna speciosa leaf extracts are lacking. In this study the antioxidant properties of water, methanolic and alkaloid M. speciosa leaf ...
<p>Current perspectives on the impact of Kratom use</p>
Charles A. Veltri, Oliver Grundmann · 2019 · Substance Abuse and Rehabilitation · 142 citations
The leaves from the tree <i>Mitragyna speciosa</i>, commonly known as Kratom, in the coffee plant family (Rubiaceae) are commonly used in their native habitat of Southeast Asia as a stimulant to su...
Reading Guide
Foundational Papers
Start with Nelsen et al. (2010, 160 citations) for acute seizure cases, Kapp et al. (2011, 139 citations) for hepatotoxicity, and Parthasarathy et al. (2009, 159 citations) for alkaloid extract properties to build core toxicology evidence base.
Recent Advances
Study Warner et al. (2015, 206 citations) for comprehensive review, Eastlack et al. (2020, 166 citations) for clinical outlook, and Wananukul et al. (2015, 130 citations) for human pharmacokinetics.
Core Methods
LC-MS for mitragynine quantification (McIntyre et al., 2014), DPPH antioxidant assays on extracts (Parthasarathy et al., 2009), and two-compartment PK modeling (Wananukul et al., 2015).
How PapersFlow Helps You Research Toxicology of Mitragyna Speciosa Alkaloids
Discover & Search
Research Agent uses searchPapers with 'Mitragyna speciosa hepatotoxicity LC-MS' to retrieve 50+ papers including Kapp et al. (2011); citationGraph maps from Warner et al. (2015, 206 citations) to foundational cases like Nelsen et al. (2010); findSimilarPapers expands to polydrug toxicology; exaSearch queries 'kratom mitragynine half-life human' for Wananukul et al. (2015).
Analyze & Verify
Analysis Agent applies readPaperContent to extract LC-MS data from Kapp et al. (2011), verifyResponse with CoVe checks mitragynine claims against 10 similar papers, runPythonAnalysis plots half-life curves from Wananukul et al. (2015) using pandas for linearity stats, and GRADE grading scores hepatotoxicity evidence as moderate due to case report biases.
Synthesize & Write
Synthesis Agent detects gaps in chronic dependence models from Cinosi et al. (2015) and flags contradictions in seizure mechanisms (Nelsen et al., 2010 vs. Eastlack et al., 2020); Writing Agent uses latexEditText for toxicity tables, latexSyncCitations for 20-paper bibliography, latexCompile for review drafts, and exportMermaid for alkaloid metabolism diagrams.
Use Cases
"Extract mitragynine concentrations from kratom fatality postmortem reports and plot vs. therapeutic levels"
Research Agent → searchPapers('kratom postmortem mitragynine') → Analysis Agent → readPaperContent(McIntyre et al. 2014 + Holler et al. 2011) → runPythonAnalysis(pandas df of LC-MS data, matplotlib log-scale plot) → researcher gets CSV of concentrations and toxicity threshold graph.
"Compile LaTeX review of kratom hepatotoxicity with citations from 15 papers"
Research Agent → citationGraph(Warner et al. 2015) → Synthesis Agent → gap detection(chronic vs. acute) → Writing Agent → latexEditText(structured sections) → latexSyncCitations(20 refs incl. Kapp 2011) → latexCompile(PDF) → researcher gets camera-ready toxicology review.
"Find GitHub repos analyzing kratom LC-MS datasets from papers"
Research Agent → searchPapers('Mitragyna LC-MS dataset') → Code Discovery → paperExtractUrls(Grundmann papers) → paperFindGithubRepo → githubRepoInspect(Python scripts) → researcher gets runnable Jupyter notebooks for mitragynine quantification.
Automated Workflows
Deep Research workflow scans 50+ kratom toxicology papers via searchPapers → citationGraph → DeepScan 7-steps with CoVe checkpoints on hepatotoxicity claims from Kapp et al. (2011), outputting GRADE-scored systematic review. Theorizer generates hypotheses on mitragynine dependence from Cinosi et al. (2015) + Henningfield et al. (2017), chaining gap detection → exportMermaid signaling pathways.
Frequently Asked Questions
What defines toxicology of Mitragyna speciosa alkaloids?
It covers acute effects like seizures (Nelsen et al., 2010) and chronic hepatotoxicity (Kapp et al., 2011) from mitragynine via case reports and LC-MS.
What are main toxicology methods used?
LC-MS for postmortem mitragynine (McIntyre et al., 2014), DPPH assays for alkaloid extracts (Parthasarathy et al., 2009), and pharmacokinetic modeling (Wananukul et al., 2015).
What are key papers on kratom toxicology?
Warner et al. (2015, 206 citations) reviews pharmacology/toxicology; Nelsen et al. (2010, 160 citations) details seizures; Kapp et al. (2011, 139 citations) reports cholestasis.
What open problems exist in kratom alkaloid toxicology?
Standardized animal hepatotoxicity models, polydrug interaction isolation, and long-term dependence receptor mechanisms lack data beyond surveys (Henningfield et al., 2017).
Research Alkaloids: synthesis and pharmacology with AI
PapersFlow provides specialized AI tools for Pharmacology, Toxicology and Pharmaceutics researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Toxicology of Mitragyna Speciosa Alkaloids with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Pharmacology, Toxicology and Pharmaceutics researchers